| The Biopharma industry is an industry dependent on | | | | economic power of China. China's manufacturing |
| investment, therefore it is extremely vulnerable to | | | | indexes have decreased considerably; however, China |
| the economic climate. When the economy is booming | | | | still presents a strong positive growth rate, a large |
| so is the Biopharma industry, including pharmaceutical | | | | investment community, and good cooperation with |
| consulting firms, life sciences consulting firms, and | | | | Western companies. Right now it is home to more |
| pharmaceutical sales consulting firms all over the | | | | than 500 Biopharma companies, and is spreading |
| country. But when the economy is in a downward | | | | throughout the rest of Asia. India's Biopharma |
| trend, the biotech industry, not to mention service | | | | Industry is growing everyday. Their clinical research |
| suppliers and vendors, are all affected. | | | | rate is growing at a such a staggering rate that soon |
| In today's bad economy we all know this to be true. | | | | they will be in the Top 5 worldwide. |
| New technologies and product ideas have taken a | | | | These are great signs for the BioPharma industry as |
| back seat to stock market figures. Serious lay-offs, | | | | their growth will be the barometer of their success. |
| outsourcing, and mergers have cut the industry down | | | | Also, their commitment to innovation will be another |
| to shreds. Outsourcing has expanded many | | | | crucial factor if this industry strives to stay profitable. |
| companies' short term sales, but has also abandoned | | | | BioPharma companies are starting to spend way |
| their long term investor equity in the process. There | | | | more capital in the research of smarter biofuels which |
| are several powerful trends taking place as we | | | | are more economical than wind, solar, and hydro |
| speak, within the Biopharma industry, as identified by | | | | options. However, as an increased use in disposables |
| life sciences consulting firms all across the country. | | | | in Biopharma manufacturing is taking place, their |
| Biopharma product approvals have been slipping for | | | | manufacturing departments are diminishing in size as |
| almost 5 years now, especially recombinant drugs, | | | | the need for capacity is decreasing. The Biopharma |
| however, the next 5 years seem more promising. As | | | | industry is as strong now as it has ever been, but will |
| more mergers take place and competition becomes | | | | it last the test of time after this economic downturn? |
| more and more fierce, many companies will need to | | | | I guess only time will tell. |
| restructure or get bought out. This trend will increase | | | | If you enjoyed this article about life sciences |
| private funding in the industry, while larger companies | | | | consulting , please feel free to post it to your site or |
| will get the rights to market the smaller companies' | | | | blog and forward this link to to your friends. Have a |
| products. | | | | great day! |
| Another trend that has developed is the growing | | | | Don't forget to visit our blog. |